Novel dataset of 160 VHH-Fc profiled across 10 biophysical assays.
They demonstrated that tabular neural networks (TabICLv2, TabPFN v2.5) trained solely on 559 IgG heavy chains outperform intra-format VHH-Fc models in zero-shot predictions, showing that training data scale outweighs structural divergence between scaffolds.
Surface-driven properties transfer with high accuracy, heparin binding (rho=.82), hydrophobicity (HIC, rho=.63), and self-association (AC-SINS, rho=0.62), whereas thermostability (Tm2, rho=0.16) remains scaffold-dependent and requires direct measurement.
Augmenting models with simple surface property inputs (HIC and HAC) boosts prediction accuracy for complex liabilities like polyreactivity (PR-CHO, rho = 0.40 to 0.51).
Evaluated ten co-folding protocols on a benchmark of 412 human monomeric antigen complexes
They demonstrate that recent architectures like Protenix v2 (52% top-1 success on post-cutoff Fv complexes) substantially outperform earlier methods like AlphaFold-Multimer (20%) and Protenix v0.5, which serves as the open-source AlphaFold3 reproduction baseline.
Modeling accuracy scaled inversely with CDR-H3 loop length. Short loops (<11 residues) were predicted accurately across all methods (0.4–0.7 Å Calpha RMSD), whereas long loops (>16 residues) remained challenging but showed distinct improvement in Protenix v2 (median 2.67 Å RMSD vs. 3.22–3.88 Å in older methods).
CDR-H3 accuracy was identified as the primary structural feature distinguishing successful complex predictions DockQ \ge 0.49 from failures, demonstrating a strong inverse correlation with overall DockQ scores (Spearman rho = -0.74) and high metric discrimination (AUROC = 0.91).
Prediction failures in unconstrained models were dominated by sampling limitations (failure to generate native-like poses) rather than ipTM ranking failures; providing idealized epitope constraints or increasing seed depth successfully rescued many of these failures by guiding the search space.
Training specificity models across several domains.
Models were trained strictly on public 1D sequence data (amino acids, DNA/RNA nucleotides, and chemical SMILES) across six biological domains, requiring no 3D structural information.
Base sequence encoders were kept frozen while small 5–7 million parameter projection heads were trained in under an hour per fold on a single GPU using thermodynamic contrastive learning.
Development was driven entirely via natural-language prompts by a domain expert with zero coding experience, with all numerical claims verified by an independent AI auditor.
Top-1 target retrieval accuracy reached up to 98.0% from pools of 512 candidates, successfully generalizing to unseen rare HLA alleles and non-canonical binding targets that rule-based tools miss.
Used as re-ranking filters alongside existing computational workflows, the models dramatically boosted precision, such as raising CRISPR off-target prediction precision from 33.2% to 94.0%.
Novel way (ProteinDPO) to apply pre-trained models to biophysical readouts.
ProteinDPO is the first framework to apply Direct Preference Optimization (introducing a novel scalar-weighted DPO objective) to align protein generative models with experimental biophysical data, without overfitting like traditional supervised fine-tuning.
Despite training exclusively on small monomeric stabilities, ProteinDPO generalizes zero-shot to accurately rank the thermal melting temperatures of multichain antibodies and score antibody-antigen binding affinities.
Applied to H5N1 influenza hemagglutinin, it generated stabilized variants yielding up to a 32C improvement in thermal stability while retaining strong nanomolar binding affinity to broadly neutralizing anti-HA antibodies.
A restriction free reproduction of the antibody design workflow germinal
Replaces proprietary dependencies (PyRosetta, IgLM) with an open-source toolchain (OpenMM, AbLang1, sc-rs) and fixes multi-chain bugs, enabling unrestricted academic and commercial deployment.
Demonstrates that AbLang1-guided hallucination significantly increases initial cofolding pass rates (e.g., 33.7% vs. 18.6% for PD-L1) with equal or higher structural confidence, at the cost of a ~1.5x increase in per-trajectory compute time.
Uses hard-coded placeholder values for three energy metrics which degrades ensemble selection and disables the interface hydrogen-bond filter and lacks wet-lab experimental validation of the generated binders.
Benchmarking of some structural prediction methods on antibody-related tasks.
Benchmarked five computational tools across two core tasks: AlphaFold3 (AF3), ImmuneBuilder (ABodyBuilder2/ABB2), and IgFold for antibody variable fragment (Fv) structure prediction, as well as AF3, dyMEAN, and GRAMM for antigen–antibody complex structure prediction and docking.
Tools were tested on 50 non-redundant humanized antibody–antigen Fab complexes from the Protein Data Bank (PDB), filtered for resolution < 3.0Å and released after December 19, 2023, to eliminate training data overlap.
All Fv predictors achieved high backbone accuracy (mean TM-score > 0.97), but AF3 demonstrated statistically significant advantages in global Fv geometry and hypervariable CDR-H3 loop modeling (median CDR-H3 RMSD of 0.86 Å, compared to 1.34 Å for ABB2 and 1.52 Å for IgFold). In complex prediction, AF3 substantially outperformed dyMEAN and GRAMM, generating reliable docking poses for 46% of complexes, whereas classical rigid-body docking (GRAMM) and epitope-guided modeling (dyMEAN) almost completely failed.
Paratope and epitope residue recovery is strictly dependent on initial docking accuracy. When docking succeeds, AF3 reliably identifies interface residues (F1 score ~ 0.85/0.87), salt bridges (84% recall), and non-bonded contacts (75% recall).
Novel method, DeepAAAssembly, to model antibody antigen complexes, beating AF3.
DeepAAAssembly introduces a hybrid framework that pairs deep learning inter-chain distance predictions with flexible Monte Carlo sampling, overcoming the lack of strong co-evolutionary signals in antibody-antigen interfaces.
The pipeline feeds Voronoi tessellation contact geometry, AntiBERTy embeddings, and a Triangular Awareness module into a multi-column CNN, creating continuous multi-peak distance energy landscapes to guide both global orientation sampling and local CDR loop refinement.
Evaluated on Docking Benchmark 5.5, it surpassed AF3 with a 12.9% higher average DockQ score on best-generated models (0.454 vs. 0.402) and boosted the overall modeling success rate (DockQ > 0.23) from 47.8% to 56.7%.
Demonstrates strong generalization on CASP15/16 blind targets by successfully correcting severe initial orientation errors, elevating previously failed structural predictions into acceptable, physically plausible models
Evaluated on SKEMPI v2.0 and SAbDab curated into three subsets: AbAgA (1,953 labeled affinity pairs), AbAgI (7,725 unlabeled interaction pairs), and AbAgKoff (272 kinetic pairs).
Compared against five PLM-based baseline setups, A2binder, AntiBERTa2, DG-Affinity, ESM-F, and AntiBERTY-F, which adapt pre-trained language models with regression heads for affinity tasks.
Generates pseudo-labels on 7,725 unlabeled pairs (AbAgI) using a teacher model trained on AbAgA; retraining on this expanded pool serves as the main engine for gains, boosting Pearson correlation from 0.45 to 0.68 and reducing MSE by ~35%.
Infuses explicit biological priors into sequence representations via an MEI module (sequence-based biophysical epitope features), CDR-masked attention (CAttention), and a Mixture-of-Experts (MoE) network to dynamically model diverse binding modes.
Extends beyond static equilibrium affinity (K_d) by using few-shot transfer learning on learned interaction features to predict dissociation rates (k_off) for target residence time analysis.
Results from the antibody discovery competition, where ML methods faced off with experimental baselines.
Participating organizations were evaluated across three tasks on a SARS-CoV-2 receptor-binding domain (RBD) dataset: (1) in silico affinity maturation by modifying non-HCDR3 CDRs using sequencing outputs, (2) affinity ranking of candidates within three HCDR3-clustered sequence datasets, and (3) out-of-library CDR optimization/design to generate novel high-affinity binders not present in the sequencing data.
For lead optimization, top ML methods matched experimental performance by producing sub-100 pM binders (top ML design: 95 pM vs. best experimental control: 113 pM), though overall ML submissions underperformed relative to experimental sorting libraries. Notably, a simple non-ML statistical consensus baseline also achieved a highly competitive 540 pM affinity without using machine learning.
For sequence ranking within HCDR3 clusters, almost all ML algorithms performed worse than random clone picking; only 9.8%-13.8% of ML submissions beat the cluster baseline clone compared to 39% from random selection. Additionally, out-of-library ML designs yielded a high proportion of non-binders (30.4%) and top-ranked affinity hits frequently suffered from severe biophysical developability failures.
ML is genuinely useful for timeline reduction during lead optimization and affinity maturation, replacing 2-3 weeks of physical combination library construction with an in silico step when provided with deep, biologically grounded experimental datasets.
Pretrained protein language models (PLMs) paired with structure-aware modules (e.g., pairformers) showed utility in exploring novel out-of-library sequence spaces. However, current ML models lack cross-task generalization, struggle with local epistasis, and fail to reliably co-optimize affinity alongside multiparametric biophysical developability.
Benchmarking the ability of co-folding models to distinguish nanobody binders and non-binders.
Evaluated four state-of-the-art structure prediction models (AlphaFold3, Boltz-2, Chai-1, and IntFold) across true binder ranking, out-of-distribution (OOD) sequence detection, and mutational sensitivity in nanobody–antigen complexes.
Discovered that no single confidence score excels across all tasks: while Boltz-2 achieved the highest median accuracy for true binder identification, local metrics like PLDDT (particularly in AlphaFold3) were far superior at catching OOD alanine-substituted sequences.
Contributed a original in vivo camelid immunization dataset targeting CD33, revealing that all evaluated models struggle to generalize when discriminating enriched binders from realistic immune repertoire background sequences.
Demonstrated that commonly used hard filtering thresholds (e.g., pAE < 10) can erroneously discard up to 75% of true binders, underscoring the need to combine complementary global interface and local CDR metrics rather than relying on single confidence scores.